Recent Advances in Biomaterials-Based Therapies for Alleviation and Regeneration of Traumatic Brain Injury

Macromol Biosci. 2023 May;23(5):e2200577. doi: 10.1002/mabi.202200577. Epub 2023 Feb 19.

Abstract

Traumatic brain injury (TBI), a major public health problem accompanied with numerous complications, usually leads to serve disability and huge financial burden. The adverse and unfavorable pathological environment triggers a series of secondary injuries, resulting in serious loss of nerve function and huge obstacle of endogenous nerve regeneration. With the advances in adaptive tissue regeneration biomaterials, regulation of detrimental microenvironment to reduce the secondary injury and to promote the neurogenesis becomes possible. The adaptive biomaterials could respond and regulate biochemical, cellular, and physiological events in the secondary injury, including excitotoxicity, oxidative stress, and neuroinflammation, to rebuild circumstances suitable for regeneration. In this review, the development of pathology after TBI is discussed, followed by the introduction of adaptive biomaterials based on various pathological characteristics. The adaptive biomaterials carried with neurotrophic factors and stem cells for TBI treatment are then summarized. Finally, the current drawbacks and future perspective of biomaterials for TBI treatment are suggested.

Keywords: adaptive biomaterials; inflammation regulation; tissue environment; tissue regeneration; traumatic brain injury.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biocompatible Materials* / pharmacology
  • Biocompatible Materials* / therapeutic use
  • Brain Injuries, Traumatic* / complications
  • Brain Injuries, Traumatic* / therapy
  • Humans
  • Nerve Regeneration
  • Neurogenesis
  • Stem Cells

Substances

  • Biocompatible Materials